30-day FRN

35373

Federal Register / Vol. 81, No. 106 / Thursday, June 2, 2016 / Notices
Inventors: Xiaoyuan Chen and Guizhi
Zhu (both of NIBIB).
Intellectual Property: HHS Reference
No. E–149–2016/0; U.S. Provisional
Patent Applications 62/331,890 filed
May 4, 2016.
Licensing Contact: Michael
Shmilovich, Esq, CLP; 301–435–5019;
shmilovm@mail.nih.gov.
Dated: May 26, 2016.
Michael Shmilovich,
Senior Licensing and Patenting Manager,
National Heart, Lung, and Blood Institute,
Office of Technology Transfer and
Development.
[FR Doc. 2016–12892 Filed 6–1–16; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; The Study of
Center of Global Health’s (CGH)
Workshops (NCI)
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Cancer Instititue, the National Institutes
of Health, has submitted to the Office of
Management and Budget (OMB) a
request for review and approval of the
information collection listed below.
This proposed information collection
was previously published in the Federal
Register on March 1, 2016 and page
10638 and allowed 60 days for public
comment. No public comments were
received. The purpose of this notice is
to allow an additional 30 days for public
comment. The National Cancer Institute,
NCI, National Institutes of Health, may
not conduct or sponsor, and the

SUMMARY:

respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
DATES: Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, or request more
information on the proposed project,
contact*: Sudha Sivaram, National
Cancer Institute Center for Global
Health, 9609 Medical Center Dr., Rm
3W528, Rockville, MD 20850 or call
non-toll-free number (240) 276–5815 or
Email your request, including your
address to: sudha.sivaram@nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
Proposed Collection: The Study of the
Center of Global Health’s (CGH)
Workshops (NCI), 0925–0722,
Expiration Date 06/30/2018, REVISION,
National Cancer Institute (NCI),
National Institutes of Health (NIH).
Need and Use of Information
Collection: This study is collecting
stakeholder feedback from past and
future workshops; to assess the
effectiveness of the Center of Global
Health (CGH) workshops, which seek to

assess abilities of the workshop
attendees and respective countries to
implement national cancer control
programs; inform content and improve
delivery of future workshops, and to
systematically assess CGH’s
contribution. The workshops to be
studied are the Symposiums on Global
Cancer Research, Workshops in Cancer
Control Planning and Implementation,
the Summer Curriculum in Cancer
Prevention, Women’s Cancer Program
Summit, Regional Grant Writing and
Peer Review Workshops, and
Workshops on Tobacco Control. While
these workshops differ in content and
delivery style, their underlying goals are
the same; they intend to initiate and
enhance cancer control efforts, increase
capacity for cancer research, foster new
partnerships, and create research and
cancer control networks. The proposed
study requests information about the
outcomes of each of these workshops
including (1) new cancer research
partnerships and networks (2) cancer
control partnerships and networks, (3)
effects on cancer research, and (4) effect
on cancer control planning and
implementation efforts. Information will
be collected in two phases where Phase
1 will collect information from
attendees of past workshops (1998–
2015) and Phase 2 will collect
information from attendees of future
workshops over the next three years.
The surveys will enable CGH to better
understand the impact the workshops
have had on their partnerships and
networks, research, and cancer control
planning and implementation efforts.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
941.

asabaliauskas on DSK3SPTVN1PROD with NOTICES

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
per year

Type of respondents

Form name

Chief Executives, Medical Scientists,
Health Educators, Family/General
Practitioners, Registered Nurses,
Medical and Health Services Managers.

Phase 1: Symposium on Global
Cancer Research.
Phase 2: Symposium on Global
Cancer Research.
Phase 1: Workshop in Cancer Control Planning and Implementation
for non-Ministry of Health participants.
Phase 2: Workshop in Cancer Control Planning and Implementation
for non-Ministry of Health participants.
Phase 1: Workshop in Cancer Control Planning and Implementation
for Ministry of Health.

VerDate Sep<11>2014

20:01 Jun 01, 2016

Jkt 238001

PO 00000

Frm 00081

Fmt 4703

Sfmt 4703

Number of
responses
per
respondent

Average
burden per
response
(in hours)

Total
annual
burden
hours

500

1

20/60

167

250

1

20/60

84

70

1

20/60

23

70

1

20/60

23

70

1

20/60

23

E:\FR\FM\02JNN1.SGM

02JNN1

35374

Federal Register / Vol. 81, No. 106 / Thursday, June 2, 2016 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued

Type of respondents

Number of
respondents
per year

Form name

Phase 2: Workshop in Cancer Control Planning and Implementation
for Ministry of Health.
Phase 1: Summer Curriculum in
Cancer Prevention (Attach 3D).
Phase 2: Summer Curriculum in
Cancer Prevention.
Phase 1: Women’s Cancer Program
Summit.
Phase 2: Women’s Cancer Program
Summit.
Phase 1: Regional Grant Writing
and Peer Review Workshop.
Phase 2: Regional Grant Writing
and Peer Review Workshop.
Phase 1: Workshops on Tobacco
Control.
Phase 2: Workshops on Tobacco
Control.
Totals ..........................................

..........................................................

Dated: May 26, 2016.
Karla Bailey,
Project Clearance Liaison, National Cancer
Institute, NIH.
[FR Doc. 2016–12995 Filed 6–1–16; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health

asabaliauskas on DSK3SPTVN1PROD with NOTICES

Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Sensory and Cognitive Processes.
Date: June 21–22, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.

VerDate Sep<11>2014

18:30 Jun 01, 2016

Jkt 238001

Frm 00082

Fmt 4703

Sfmt 4703

Average
burden per
response
(in hours)

Total
annual
burden
hours

70

1

20/60

23

500

1

30/60

250

27

1

30/60

14

140

1

20/60

47

140

1

20/60

47

150

1

30/60

75

60

1

30/60

30

180

1

30/60

90

90

1

30/60

45

2,317

2,317

........................

941

Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Jana Drgonova, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 5213,
Bethesda, MD 20892, jdrgonova@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Drug Discovery and Development.
Date: June 27, 2016.
Time: 8:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westin St. Francis, 335 Powell
Street, San Francisco, CA 94102.
Contact Person: Sergei Ruvinov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158,
MSC 7806, Bethesda, MD 20892, 301–435–
1180, ruvinser@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Pregnancy and Neonatology Study Section.
Date: June 28–29, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Michael Knecht, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6176,
MSC 7892, Bethesda, MD 20892, (301) 435–
1046, knechtm@csr.nih.gov.

PO 00000

Number of
responses
per
respondent

Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Molecular and Cellular Substrates of
Complex Brain Disorders.
Date: June 28, 2016.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington Embassy Row,
2015 Massachusetts Avenue NW.,
Washington, DC 20036.
Contact Person: Deborah L. Lewis, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4183,
MSC 7850, Bethesda, MD 20892, 301–408–
9129, lewisdeb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Nephrology.
Date: June 28–29, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Atul Sahai, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2188,
MSC 7818, Bethesda, MD 20892, 301–435–
1198, sahaia@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Integrative Nutrition and Metabolic Processes
Study Section.
Date: June 28, 2016.
Time: 8:00 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westin Georgetown, 2350 M
Street NW., Washington, DC 20037.

E:\FR\FM\02JNN1.SGM

02JNN1